Vázquez, Luis Alberto http://orcid.org/0000-0003-4929-4479
Romera, Irene http://orcid.org/0000-0002-1345-9799
Rubio-de Santos, Miriam http://orcid.org/0000-0001-7393-6334
Escalada, Javier http://orcid.org/0000-0001-5877-9465
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 11 April 2023
Accepted: 24 August 2023
First Online: 15 September 2023
Declarations
:
: Luis Alberto Vázquez is a former employee and minor shareholder of Eli Lilly and Company and has participated as speaker, advisor and investigator for Eli Lilly and Company, NovoNordisk, Astra-Zeneca and Boehringer-Lilly. Irene Romera and Miriam Rubio-de Santos are employees and minor shareholders of Eli Lilly and Company. Javier Escalada has participated as speaker, advisor and investigator for Astra-Zeneca, Boehringer, Eli Lilly and Company, NovoNordisk and Sanofi.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.